Study Links Subcortical Brain Changes to Anxiety in Early Parkinson's Disease

Led by Guillaume Carey from Maastricht University’s Mental Health and Neurosciences Research Institute, the study examined participants from the TRACK-PD cohort, a longitudinal study registered in the Dutch Trial Register. The research involved 105 non-demented Parkinson’s patients, of whom 31 reported clinically significant anxiety, alongside 37 healthy controls. All participants underwent structural brain scans on a 7 Tesla MRI scanner, which offers substantially greater anatomical detail compared to the more commonly used 3 Tesla MRI.

The focus was on several small yet vital brain structures: the amygdala, hippocampus, nucleus accumbens, caudate nucleus, putamen, and thalamus. These regions play essential roles in emotion, reward, and threat processing and are significantly impacted by dopaminergic neurodegeneration in Parkinson’s disease. The precision of measurements was enhanced by using high-resolution imaging and advanced computational techniques.

To quantify the brain scans, researchers employed FastSurfer, a deep-learning segmentation tool, and complemented this with a shape analysis method known as Spherical Harmonics Point Distribution Model (SPHARM-PDM). This approach allows for the representation of three-dimensional structures and can identify localized deformations that may indicate neurodegenerative changes.

The findings revealed a notable correlation between anxiety severity and reduced caudate volume: patients with higher anxiety showed smaller caudate nuclei on both sides. The caudate, integral to the brain’s reward and motivation systems, also connects with regions responsible for managing fear and worry, suggesting that anxiety may reflect underlying neural circuit degeneration rather than merely a psychological response to the diagnosis.

Shape analysis provided further insights, demonstrating distinct shape deformations in anxious patients compared to non-anxious ones in structures like the bilateral caudate, bilateral thalamus, left nucleus accumbens, and left amygdala. Comparisons with healthy controls highlighted significant shape differences in the left amygdala and left thalamus, indicating broader structural remodeling across the emotional processing network in early Parkinson’s.

Notably, the study emphasizes the importance of early-stage research, as prior imaging studies often focused on mid or late-stage patients, complicating the isolation of specific symptoms' biology. By analyzing only non-demented patients in the early phases, the researchers aimed to determine if anxiety presents its own structural signature prior to extensive brain alterations, which the results suggest it does.

The authors propose that these morphological changes could become potential neuroimaging markers for diagnosing and tracking anxiety in early Parkinson’s disease. Such markers may help differentiate anxiety rooted in neural degeneration from situational distress, thus improving the identification and treatment of at-risk patients.

However, the study has limitations typical of cross-sectional designs; it shows associations rather than establishing causation. The anxious patient group was relatively small, indicating the need for longitudinal studies to confirm if the observed changes predict future anxiety symptoms. The researchers, alongside the TRACK-PD infrastructure, are positioned to explore these questions as they continue to track the cohort over time.

This research represents a significant advance, demonstrating that 7 Tesla MRI, with automated segmentation and shape modeling, can reveal subtle structural differences in deep brain nuclei. It repositions anxiety in Parkinson’s disease as a circuit-level condition with discernible anatomical ties, offering potential biomarkers targeting the striatum, thalamus, and amygdala. Future research confirming these findings could facilitate early identification of anxiety symptoms and assess the efficacy of new interventions.